Conversion of the C3 component of complement in sera of hanseniasis patients

Insights

Complement C3 conversion is elevated in Virchowian and erythema nodosum Hansenicum leprosy patients, indicating complement system activation. Total C3 levels remained unchanged across patient groups and normal individuals.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biochemistry

Background:

  • Leprosy is a chronic infectious disease caused by Mycobacterium leprae.
  • The complement system plays a crucial role in immune responses to infections.
  • Previous studies suggest complement involvement in leprosy pathogenesis.

Purpose of the Study:

  • To investigate complement C3 (C3) levels and conversion rates in different leprosy types.
  • To explore the association between C3 conversion and leprosy clinical forms.
  • To understand the role of complement activation and immune complexes in leprosy.

Main Methods:

  • Sera from leprosy patients (Virchowian, Tuberculoid, Indeterminate, ENH) and normal individuals were analyzed.
  • Quantification of total C3 and its degradation products.
  • Assessment of the percentage of C3 conversion into breakdown products.

Main Results:

  • Total C3 levels did not significantly differ among leprosy types and normal controls.
  • The percentage of C3 conversion was significantly higher in Virchowian (V) and Erythema Nodosum Hansenicum (ENH) sera.
  • Elevated C3 conversion suggests complement system activation in these leprosy forms.

Conclusions:

  • Complement C3 conversion, not total C3 levels, is a key indicator of complement activation in leprosy.
  • Virchowian leprosy and ENH are associated with increased complement system activity.
  • Immune complex involvement in complement activation warrants further investigation in leprosy.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...